CLOs on the Move

Argentis Pharmaceuticals

www.argentisrx.com

 
arGentis™ Pharmaceuticals, LLC is a private TN based pharmaceutical company with a mid-stage Orphan Drug treatment (ARG201) for late stage diffuse systemic scleroderma (dcSSc). The company is seeking capital or a partner to complete a Pivotal Clinical Trial which will enable obtaining marketing approval in the EU. The Company has a genotype marker (ROT1) that predicts patient response to treatment by oral tolerance for treatments like ARG201 for dcSSc. Furthermore, arGentis™ has a treatment for Rheumatoid arthritis (ARG301) that is in a Phase I Clinical Trial in the US.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.argentisrx.com
  • 1016 W. Poplar Ave. Suite 106-238
    Collierville, TN USA 38017
  • Phone: 901.881.8665

Executives

Name Title Contact Details

Similar Companies

NovaBioMed Inc

NovaBioMed Inc is a Kentville, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Midwest Eye Consultants

Midwest Eye Consultants provides total eye care from eye health exams to the treatment of eye diseases. See our locations page to find an office near you.

JandS Studies

J&S Studies, Inc. is a Bryan, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Bottled Fitness

Bottled Fitness is a Valparaiso, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ARYx Therapeutics

ARYx Therapeutics, Inc. is a Fremont, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.